CD19 and non-Hodgkin lymphoma: Studies focused on the diagnostic value of CD19-directed CAR T-cells generated using the DNA transposon systems; the studies included adult patients and pediatric patients who have hematological malignancies like ALL, NHL, and chronic lymphocytic leukemia (CLL).